卵巢癌属于较为常见的恶性肿瘤,具有轻易扩散和病症隐蔽的特点,大多数患者在就诊时就已经进入晚期阶段,因此直接错过了最佳的治疗时期。目前对于晚期卵巢癌主要还是采用药物治疗的方式,紫杉醇联合顺铂类药物在治疗晚期卵巢癌当中受到广泛的应用和认可。然而,由于患者本身免疫性相对偏低,在接受化疗的同时,其自身免疫功能受到明显的抑制,对患者的恢复速度及耐受性造成了严重的影响,为此,本院推出紫杉醇联合顺铂腹腔和静脉的治疗方式。本文选取 Ovarian cancer is a common malignant tumor, with the characteristics of easy proliferation and occult disease. Most patients have entered the advanced stage at the time of treatment and thus directly miss the optimal treatment period. At present, mainly for advanced ovarian cancer drug treatment, paclitaxel plus cisplatin drugs in the treatment of advanced ovarian cancer which has been widely used and recognized. However, due to the relatively low immunity of patients, the autoimmune function of chemotherapy is obviously inhibited, which has a serious impact on the recovery speed and tolerability of patients. Therefore, the hospital launched the combination of paclitaxel Placenta and vein treatment of platinum. This article selected